MedPath

FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

801

Active:73
Completed:195

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:10
Phase 2:25
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (337 trials with phase data)• Click on a phase to view related trials

Not Applicable
269 (79.8%)
Phase 2
25 (7.4%)
Phase 4
18 (5.3%)
Phase 3
12 (3.6%)
Phase 1
10 (3.0%)
Early Phase 1
2 (0.6%)
phase_1_2
1 (0.3%)

Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.

Not yet recruiting
Conditions
Venous Thromboembolism
Obese Patients
First Posted Date
2025-10-09
Last Posted Date
2025-10-09
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
80
Registration Number
NCT07213713

Organoids for Bile Leaks

Not Applicable
Not yet recruiting
Conditions
Biliary Anastomosis Complication
Interventions
Biological: Organoid-guided treatment
First Posted Date
2025-10-09
Last Posted Date
2025-10-09
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
25
Registration Number
NCT07214649

No-Stoma Policy in Advanced Ovarian Cancer Surgery

Not Applicable
Recruiting
Conditions
Ovary Cancer
First Posted Date
2025-10-08
Last Posted Date
2025-10-08
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
395
Registration Number
NCT07213193
Locations
🇮🇹

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Ginecologia Oncologica, Roma, Italy

IL-6 and Lactates in Cord Blood and Neonatal Outcomes

Not yet recruiting
Conditions
Fetal Infection
Fetal Inflammatory Response Syndrome
Chorioamnionitis
Chorioamnionitis Affecting Fetus or Newborn
First Posted Date
2025-10-08
Last Posted Date
2025-10-08
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
160
Registration Number
NCT07211503
Locations
🇮🇹

Policlinico Gemelli, Roma, RM, Italy

GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study

Not yet recruiting
Conditions
Glaucoma Open-Angle Primary
Ocular Hypertension
First Posted Date
2025-10-07
Last Posted Date
2025-10-07
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
60
Registration Number
NCT07210216
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 157
  • Next

News

EndoZip™ Automated Endoscopic System Shows 11.4% Weight Loss and Improved Comorbidities in Obesity Trial

Interim clinical data from the EndoZip™ automated endoscopic suturing system demonstrated an average total body weight loss of 11.4% at twelve months in patients with class I and II obesity.

Secure Multiparty Computation Enables Privacy-Friendly Evaluation of Patient Data in Adrenal Gland Metastasis Study

A bicenter, prospective, longitudinal observational study utilized MR-guided radiotherapy (MRgRT) to treat adrenal gland metastasis, emphasizing precision and minimizing radiation exposure.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.